企业邮箱
MEBO Group Hosts “Asia-Pacific Health Community Gala Dinner” in Seoul, Advancing Regional Cooperation in Health and Culture
On October 19, 2025, MEBO Group successfully hosted the Asia-Pacific Health Community Gala Dinner in Seoul, Korea, under the theme “Connectivity · Sharing · Progress.” The event gathered distinguished representatives from the Embassy of China in Korea, APEC partners, academia, and the business community to explore collaborative approaches to health governance and sustainable development across the region.
The evening featured the premiere of “Voices of Youth: Connecting APEC’s Future” and an address by Mr. Zhong Hongnuo, Minister-Counselor of the Chinese Embassy in Korea, who commended MEBO’s contributions to regional health cooperation. He highlighted MEBO’s Fellowship Program and Silver Healing Initiative as exemplary models supporting both youth development and eldercare in the Asia-Pacific.
Vice Chairman of MEBO Group, Ms. Li Li, emphasized that health is a shared human aspiration and a bridge among cultures. MEBO, a global leader in regenerative life science, remains dedicated to integrating innovation and compassion in building a resilient regional health ecosystem.
During the event, the Kevin Xu APEC Region Public Policy–SDG Fellowship Program was officially launched, providing scholarships and mentorship for young researchers under 35 from APEC economies. MEBO also announced the Silver Healing: Equitable Community Wound Care initiative to strengthen community-based eldercare systems.
The night concluded with a ceremony celebrating 30 years of partnership between MEBO International and Dongwha Pharm, marking a new phase of collaboration.
Through shared vision and sustained partnership, MEBO continues to promote dialogue, innovation, and solidarity toward a healthier, more connected Asia-Pacific community.
About MEBO
Founded in 1987 by Professor Rongxiang Xu, a distinguished Chinese life scientist, MEBO Group is a multinational headquartered in both China and the USA. It integrates research, development, and sales across the pharmaceuticals, medical devices, health foods, and cosmetics sectors.
At its core, MEBO focuses on regenerative life sciences, innovating with over 100 patents and more than ten joint research bases to enhance and enable the body's own regenerative abilities.
As a leader in regenerative life science, MEBO's extensive research facilities and products impact over 100 countries globally, pioneering new frontiers in the regenerative life world.